Latest Product Trials News

Resources & Energy Group Limited (REZ) has resumed trial gold mining at its East Menzies Gold Project, focusing on the Maranoa deposit with a vat leach method. The company anticipates its first gold pour on February 1, 2025, marking a pivotal step toward sustained production.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.

Hydrocarbon Dynamics secures a $165,000 repeat order from Dubai and closes a rights issue raising $808,582, while advancing multiple global trials of its HCD Multi-Flow product.

Strategic Elements Ltd reports a robust cash position and progress across its portfolio of early-stage ventures, including the promising Energy Ink™ technology and autonomous vehicle applications in mining.

Entyr Limited has ramped up tyre receivals and processing volumes in the December quarter, alongside securing new supply and offtake agreements as it prepares for ASX reinstatement. The company’s ongoing plant upgrades and strategic partnerships signal a potential turnaround in its operational and financial trajectory.

OM Holdings delivered a robust production update for Q4 2024, with ferrosilicon output rising sharply despite manganese ore price declines and operational challenges. The company also secured a top sustainability award and made significant debt repayments.

Zeotech Limited has secured a strategic MOU with Holcim Australia to advance its AusPozz™ low-carbon concrete product, alongside promising methane reduction results and a newly granted Japanese patent.

Entyr Limited has launched a $9.5 million capital raising via a Share Purchase Plan and Placement Offer, aiming to recapitalize and return to ASX trading following its recent voluntary administration.

Zoono Group reports expanding global trials of its shelf-life extension technology, engaging over 40 supermarket and packaging companies, while refining its product and managing cash flow amid cautious commercial adoption.